washingtonexaminer.com

washingtonexaminer.com
Share

washingtonexaminer.com

 •  October 9

Democratic California Gov. Jerry Brown is expected to sign a bill into law Monday that would require drug companies to justify planned price hikes to their medications. Under the bill, drug companies would need to notify private health insurers and the state government health plan, known as Medi-Cal, of their intentions 60 days before the price...

washingtonexaminer.com

 •  September 29

A federal judge on Friday refused to block a Maryland law aimed at expensive generic drug pricing from going into effect. The dismissal is a blow to the Association for Accessible Medicines, which represents generics and initiated the lawsuit. The organization said it was reviewing the decision. U.S. District Judge Marvin Garbis denied the...

washingtonexaminer.com

 •  September 28

The first state law going after the price of prescription drugs is set to go into effect in Maryland on Sunday, but a judge could still act to suspend the law. "We're seeking an injunction and we're waiting on a ruling," said Rachel Schwartz, spokeswoman for the Association for Accessible Medicines, which represents generic drugs. "We're waiting on...

washingtonexaminer.com

 •  September 18

Disco was king the last time regulations were finalized for the most common drugs Americans use, such as cough medicine and aspirin. So, Congress is taking a hard look at overhauling the rules for over-the-counter drugs. Lawmakers want to create a user fee program that gives the Food and Drug Administration more money to quickly revamp the...

washingtonexaminer.com

 •  August 17

Two House Democrats on Thursday accused makers of multiple sclerosis drugs with raising prices on older drugs to match the price of newer drugs from their competitors. Reps. Elijah Cummings, D-Md., and Peter Welch, D-Vt., sent letters to seven drug makers seeking answers about price hikes for MS drugs. The lawmakers, who have been investigating...

washingtonexaminer.com

 •  June 11

The Food and Drug Administration shocked lawmakers, advocates and the pharmaceutical industry when it asked a drugmaker to pull an opioid from store shelves. The agency's decision Thursday evening to ask Endo Pharmaceuticals to remove the painkiller Opana Extended Release from the market — the first such request by the FDA — came after years of...

The Food and Drug Administration isn't standing on the sidelines anymore on fighting rising drug prices. “ A major issue that has led to price spikes is companies acquiring old generics that have no competition and then jacking up the price. ” In a major shift, new Commissioner Scott Gottlieb is creating an action plan to spur more competition and...

washingtonexaminer.com

 •  March 20

Dr. Scott Gottlieb, President Trump's pick to lead the Food and Drug Administration, would take over the agency at a high-stakes time when drug costs are a top concern to the public. If confirmed by the Senate as FDA commissioner, Gottlieb would face pressing questions of how to lower quickly rising prescription drug costs in a way that would be...

washingtonexaminer.com

 •  March 11

About 16 years before he ran for president, Bernie Sanders had a transformative moment, and it involved a busload of seniors. Back in 2000, he became the first member of Congress to take seniors across the border to buy cheaper drugs in Canada. "All of us have days [that] are transformative, when something happens that we will never forget,"...

washingtonexaminer.com

 •  February 14

Winston Churchill famously described an appeaser as "one who feeds a crocodile, hoping it will eat him last." Today, in a very different context, his remark captures the plight of the American pharmaceutical industry. Roughly five years after lobbyists for drugmakers worked to help pass President Obama’s healthcare law in hopes it would fend off...